Tocilizumab in Schizophrenia

Clinical trial NCT02874573 · UNKNOWN

Trial details

NCT number: NCT02874573
Sponsor: Brian Miller
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Psychotic Disorders

Start date: 2016-09-01
Primary completion: 2023-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.